We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
101
Gotham Asset Management
New York
$14.4M -$5.47M -71,783 -29%
ACI
102
AMP Capital Investors
Australia
$13.1M +$1.13M +14,863 +10%
Mackenzie Financial
103
Mackenzie Financial
Ontario, Canada
$13M -$100K -1,318 -0.8%
SCM
104
Sarissa Capital Management
Connecticut
$12.9M -$31.7M -416,000 -72%
Federated Hermes
105
Federated Hermes
Pennsylvania
$12.7M -$5.97M -78,362 -33%
WBC
106
Westpac Banking Corp
Australia
$12.5M -$2.5M -32,806 -16%
Canada Pension Plan Investment Board
107
Canada Pension Plan Investment Board
Ontario, Canada
$12.4M +$3.19M +41,900 +38%
BIP
108
Brandes Investment Partners
California
$12M -$1.21M -15,891 -10%
CIP
109
Chartwell Investment Partners
Pennsylvania
$11.9M +$11.2M +146,724 New
Citigroup
110
Citigroup
New York
$11.9M +$744K +9,764 +7%
Manulife (Manufacturers Life Insurance)
111
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$11.5M -$248K -3,257 -2%
DIA
112
Dana Investment Advisors
Wisconsin
$11.4M +$420K +5,510 +4%
GT
113
Glenmede Trust
Pennsylvania
$11.2M +$229K +3,013 +2%
UBS Group
114
UBS Group
Switzerland
$10.7M +$591K +7,758 +6%
BGIM
115
Brandywine Global Investment Management
Pennsylvania
$10.6M -$228K -3,000 -2%
Chevy Chase Trust
116
Chevy Chase Trust
Maryland
$9.87M +$29.4K +386 +0.3%
D.E. Shaw & Co
117
D.E. Shaw & Co
New York
$9.83M -$12.3M -162,128 -57%
GH
118
GAM Holding
Switzerland
$9.77M +$3.65M +47,995 +67%
CIM
119
Calvert Investment Management
Maryland
$9.76M +$5.9M +77,465 +183%
Wellington Management Group
120
Wellington Management Group
Massachusetts
$9.62M +$4.54M +59,568 +102%
National Pension Service
121
National Pension Service
South Korea
$9.23M +$779K +10,230 +10%
DA
122
Denali Advisors
California
$9.21M +$4.18M +54,900 +94%
CCM
123
Copeland Capital Management
Pennsylvania
$9.19M -$426K -5,600 -5%
IGIM
124
I.G. Investment Management
Manitoba, Canada
$9.04M – – –
WA
125
Wasatch Advisors
Utah
$8.77M +$8.2M +107,683 New
3 4
5
6 7

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.